Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2012) 30 P29

BSPED2012 Poster Presentations (1) (66 abstracts)

Should we check vitamin D status at time of diagnosis of type 1 diabetes mellitus?

J P Smith 1 , E Crowne 1 , J P H Hamilton-Shield 2 & C Burren 1


1Department of Paediatric Endocrinology and Diabetes, Bristol Royal Hospital for Children, Bristol, UK; 2Department of Clinical Sciences, University of Bristol, Bristol, UK.


Physiology shows vitamin D has a role in the immune system and glucose metabolism. Experimental and epidemiological studies demonstrate associations between type 1 diabetes mellitus (T1DM) and vitamin D levels. Vitamin D deficiency appears undesirable in T1DM, although its significance in aetiology and progression is controversial.

We reviewed the outcome of implementing vitamin D screening at T1DM diagnosis. Methods were review of diabetes register, hospital case notes and pathology systems. Of the 46 T1DM cases diagnosed March 2011–2012, 42 were tested (seven sampling errors: six insufficient, one wrong tube). Within 1 month of diagnosis, three were re-sampled and a further child also tested, giving 39 evaluable vitamin D results (85% cases). Only 26% (10/39) had optimal levels (>75 nmol/l), 46% (18/39) suboptimal (50–75 nmol/l), 18% (7/39) insufficient (25–50 nmol/l) and 10% (4/39) were deficient (<25 nmol/l). Vitamin D levels showed no correlation with age, HbA1c or pH. There was a seasonal trend in vitamin D levels, with all four vitamin D deficiency cases diagnosed December–March (2/4 were non-Caucasian). 91% of hospital notes reviewed contained documented results. All four cases of deficiency had a treatment plan, although two had unclear documentation of implementation. Local practice guidelines have achieved increased identification and treatment of vitamin D deficiency.

Vitamin D deficiency is problematic in the UK. Ideally more children would receive preventative Vitamin D supplements if national recommendations are followed (all children under 5 years old, particularly children with other risk factors for vitamin D deficiency). The prevalence in our newly diagnosed T1DM population may simply reflect that of the wider community. Screening Vitamin D status at T1DM diagnosis provides an opportunity to address Vitamin D deficiency (<25 nmol/l) in this subgroup. Screening and treating Vitamin D at diagnosis can be advocated for the broader non-diabetes health benefits, although the potential effect on ameliorating T1DM progression requires further evaluation.

Volume 30

40th Meeting of the British Society for Paediatric Endocrinology and Diabetes

British Society for Paediatric Endocrinology and Diabetes 

Browse other volumes

Article tools

My recent searches

No recent searches.